Media Center

The Galien Foundation announces the Galien UK Forum 2026 programme

This year's Forum theme is: "The health of the future in an age of breakthrough: from discovery to the patient"

Photo: Prix Galien

The Galien Foundation, a leading global institution that honours innovators in the life sciences, has announced the programme of this year's Galien UK Forum. The event will take place on 11 June 2026 at the Science Museum in London and will bring together leading figures from science, the pharmaceutical industry and health policy. The guiding question of the forum will be how to turn breakthrough scientific discoveries into real benefits for patients. Confirmed speakers include Professor Dame Sally Davies, the UK government's Special Envoy on Antimicrobial Resistance and Master of Trinity College, Cambridge. The programme includes four panel discussions on the most important challenges in contemporary medicine: a new generation of molecular innovation, smarter design of clinical studies, reform of regulatory processes, and the introduction of precision medicine into everyday clinical practice. Experts from GSK, Novartis, the European Medicines Agency, Karolinska Institutet and leading academic centres in the United Kingdom and Europe will take part. "The Galien UK Forum reflects the spirit of collaboration that drives the most significant advances in healthcare," said Professor Sir Munir Pirmohamed of the University of Liverpool, Chair of the Galien UK Committee. "This year's theme will lead us not only to celebrate scientific excellence, but also to think critically about how medical breakthroughs can reach every patient who needs them." The forum will be preceded by the Prix Galien UK Awards gala at the Natural History Museum in London. Awards will be given in the categories: best biotechnology product, best digital health solution, best medical technology, best pharmaceutical product, best public-sector innovation, and best innovation for health equity. The Galien Foundation was established in Paris in 1970 by Roland Mehl, in honour of Galen, the father of medical science and modern pharmacology. Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research and now operates in 16 countries across Africa, Europe, the United States and the United Kingdom. Expansion is under way into South Korea, Japan, Singapore and Australia. In 2025 The Galien Foundation inaugurated the Prix Galien Bridges Forum in Stockholm, an event linking the countries of Northern and Southern Europe, Israel and the Middle East, and the first Patient Summit of Prix Galien USA.

More information

media@prixgaliencee.com

Stay up to date

Receive updates about Prix Galien Poland, Galien Forum and innovations in medicine.

Enter your email address to subscribe to our newsletter.